Diamond Pharma Services acquires PharmaCentral to strengthen pharmacovigilance division

Diamond Pharma Services, one of the leading technical services and regulatory affairs consulting group, has announced its pharmacovigilance division, Diamond PV Services, has acquired PharmaCentral, an innovative pharmacovigilance services and medical affairs business based in Dublin, Ireland. The acquisition will expand Diamond’s presence in Europe and enhance the senior-level expertise within its pharmacovigilance team.

PharmaCentral offers a wide range of pharmacovigilance consultancy services, based on a wealth of experience in pharmacovigilance and medical affairs in both pharma and CRO environments. The acquisition of PharmaCentral forms part of Diamond’s growth strategy for its pharmacovigilance division, which has achieved a Compound Annual Growth Rate (CAGR) in revenues of 27% over the last three years. This rapid expansion of Diamond’s pharmacovigilance senior level team is required to support clients from Diamond’s regulatory affairs business in specialist areas such as gene and cell therapies.

Diamond Pharma Services provides Regulatory Affairs, Pharmacovigilance and Compliance & Quality services to support pharmaceutical and biotechnology companies in obtaining and maintaining medicinal product licences throughout all stages of a product’s life cycle. Diamond will continue to expand its presence in Dublin through 2020, with recruitment across all three of its divisions.

Do you want the latest science news straight to your inbox? Become a SelectScience member for free today>>